Keros Therapeutics, Inc.
KROSNasdaqCIK 1664710HealthcareFiscal year ends Dec 31
Reports and events: 206 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2908:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001664710-26-000059 |
| 2026-09-2808:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001664710-26-000056 |
| 2026-09-0816:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001664710-26-000053 |
| 2026-08-0316:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001664710-26-000050 |
| 2026-08-0316:02 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001664710-26-000049 |
| 2026-08-0316:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001664710-26-000048 |
| 2026-07-3016:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001664710-26-000043 |
| 2026-07-2216:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001664710-26-000038 |
| 2026-06-2516:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001664710-26-000036 |
| 2026-06-0316:01 ET | 8-K | 5.07 Shareholder vote results | 0001664710-26-000034 |
| 2026-06-0116:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001664710-26-000032 |
| 2026-05-1408:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001664710-26-000030 |
| 2026-05-1408:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001664710-26-000029 |
| 2026-04-2216:01 ET | DEF 14A | Proxy statementPeriod 2026-06-03 | 0001104659-26-046791 |
| 2026-03-0908:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001664710-26-000024 |
| 2026-03-0416:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001664710-26-000021 |
| 2026-03-0416:04 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001664710-26-000018 |
| 2026-03-0416:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001664710-26-000017 |
| 2026-02-2616:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001664710-26-000008 |
| 2026-02-1816:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001664710-26-000005 |
| 2026-01-0916:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001664710-26-000003 |
| 2025-11-0516:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001664710-25-000089 |
| 2025-11-0516:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001664710-25-000086 |
| 2025-10-1617:36 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-25-002751 |
| 2025-10-1506:50 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-25-004410 |
| 2025-10-1506:40 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-099512 |
| 2025-09-0808:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001664710-25-000081 |
| 2025-08-2816:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001664710-25-000078 |
| 2025-08-2116:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-25-003804 |
| 2025-08-2009:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001664710-25-000073 |
| 2025-08-0616:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001664710-25-000071 |
| 2025-08-0616:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001664710-25-000070 |
| 2025-08-0616:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001664710-25-000068 |
| 2025-07-1708:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001664710-25-000062 |
| 2025-07-1516:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001664710-25-000059 |
| 2025-06-0906:56 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001664710-25-000057 |
| 2025-06-0616:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001664710-25-000055 |
| 2025-05-2906:58 ET | 8-K | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001664710-25-000052 |
| 2025-05-1211:29 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-25-002254 |
| 2025-05-1208:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001664710-25-000050 |
| 2025-05-0816:39 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-25-002179 |
| 2025-05-0616:03 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001664710-25-000046 |
| 2025-05-0616:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001664710-25-000045 |
| 2025-04-2818:43 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-040354 |
| 2025-04-2316:03 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0001104659-25-037982 |
| 2025-04-1817:10 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001999371-25-004429 |
| 2025-04-1817:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001664710-25-000038 |
| 2025-04-1120:32 ET | SCHEDULE 13D | Ownership report, active investor | 0001104659-25-034310 |
| 2025-04-1006:01 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001664710-25-000033 |
| 2025-03-3106:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001664710-25-000029 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:11 ET. Listed shows no prices and gives no investment advice.